Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Between Bedside and Bench
  • Published:

Weighing in on autoimmune disease: Big data tip the scale

Modern medicine keeps unraveling new ways to investigate autoimmunity, leading to the production of boundless amounts of genetic, cellular and imaging data. Although the precision with which this information can define the etiology and mechanisms of a particular autoimmune disease is encouraging, much work lies ahead until all the knowledge acquired can be translated into the clinic. In 'Bedside to Bench', Calliope A. Dendrou, John I. Bell and Lars Fugger discuss the promises and limitations of genome-wide and next-generation genetic studies to provide further understanding of mechanisms driving autoimmune disorders and the role of experimental medicine in the new era of integrative clinical practice and personalized medicine. In 'Bench to Bedside', Lawrence Steinman argues the concept of a 'hub and spoke' pattern of T cell activation and organ targeting in multiple sclerosis, inflammatory bowel disease and type 1 diabetes. This paradigm suggests new ways to develop drugs to keep autoreactive T cells in the organ where activation occurs and preclude them from reaching the target organ and cause disease.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Genetic risk factors and established points of drug intervention in the interleukin-23 (IL-23)–IL-17 axis in psoriasis.


  1. Lewis, T. Lancet 243, 649–651 (1944).

    Article  Google Scholar 

  2. Kitley, J. et al. Brain 135, 1834–1849 (2012).

    Article  Google Scholar 

  3. Klareskog, L., Gregersen, P.K. & Huizinga, T.W. Ann. Rheum. Dis. 69, 2062–2066 (2010).

    Article  CAS  Google Scholar 

  4. Curtis, C. et al. Nature 486, 346–352 (2012).

    Article  CAS  Google Scholar 

  5. Su, F. et al. N. Engl. J. Med. 366, 207–215 (2012).

    Article  CAS  Google Scholar 

  6. Dixon-Salazar, T.J. et al. Sci. Transl. Med. 4, 138ra78 (2012).

    Article  Google Scholar 

  7. Tsoi, L.C. et al. Nat. Genet. 44, 1341–1348 (2012).

    Article  CAS  Google Scholar 

  8. Griffiths, C.E.M. et al. N. Engl. J. Med. 362, 118–128 (2010).

    Article  CAS  Google Scholar 

  9. Leonardi, C. et al. N. Engl. J. Med. 366, 1190–1199 (2012).

    Article  CAS  Google Scholar 

  10. Gregory, A.P. et al. Nature 488, 508–511 (2012).

    Article  CAS  Google Scholar 

  11. Cortes, A., Robinson, P. & Brown, M.A. Arthritis Rheum. 64, S1053–S1054 (2012).

    Google Scholar 

  12. Braun, J. et al. Lancet 359, 1187–1193 (2002).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Lars Fugger.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dendrou, C., Bell, J. & Fugger, L. Weighing in on autoimmune disease: Big data tip the scale. Nat Med 19, 138–139 (2013).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research